Home > Healthcare > Drug Device Combination > Therapeutic Systems > Oncolytic Virotherapy Market
Oncolytic Virotherapy Market Size
- Report ID: GMI9645
- Published Date: May 2024
- Report Format: PDF
Oncolytic Virotherapy Market Size
Oncolytic Virotherapy Market size was valued at USD 20.1 million in 2023 and is anticipated to showcase growth at 26.9% CAGR from 2024 and 2032. Rising incidence of cancer, growing approvals for oncolytic therapy for treating rare cancers, and increasing investments for developing new oncolytic virotherapies are driving the revenue growth in market. Additionally, growing focus towards combination therapies is also driving the market.
Oncolytic virotherapy is a form of cancer treatment that uses viruses to selectively infect, replicate within, and destroy cancer cells while sparing normal cells. Oncolytic viruses are typically engineered to target and replicate in tumor cells, leading to their destruction through direct lysis, induction of apoptosis, or through stimulating the immune system's anti-tumor response.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Oncolytic Virotherapy Market Size in 2023: | USD 20.1 Million |
| Forecast Period: | 2024 - 2032 |
| Forecast Period 2024 - 2032 CAGR: | 26.9% |
| 2032 Value Projection: | USD 169.4 Million |
| Historical Data for: | 2021 – 2023 |
| No. of Pages: | 125 |
| Tables, Charts & Figures: | 228 |
| Segments covered: | Virus type, Application, End user, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Oncolytic Virotherapy Market Scope
